Patent details

EP3571193 Title: POTASSIUM CHANNEL MODULATORS

Basic Information

Publication number:
EP3571193
PCT Application Number:
US2018014792
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187041223
PCT Publication Number:
WO2018136917
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POTASSIUM CHANNEL MODULATORS
French Title of Invention:
MODULATEURS DE CANAUX POTASSIQUES
German Title of Invention:
KALIUMKANALMODULATOREN
SPC Number:

Dates

Filing date:
23/01/2018
Grant date:
01/12/2021
EP Publication Date:
27/11/2019
PCT Publication Date:
26/07/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/12/2021
EP B1 Publication Date:
01/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/01/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/03/2023
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

History of Owners

From:
21/03/2023
To:
21/03/2023

Name:
CADENT THERAPEUTICS, INC.
Address:
One Health Plaza East Hanover,, New Jersey, 07936, United States (US)

From:
24/11/2021
To:
21/03/2023

Name:
Cadent Therapeutics, Inc.
Address:
60 Hamilton Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
13/01/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
NIELSEN, Karin, Sandager
Address:
Denmark (DK)

2

Name:
JACOBSEN, Thomas, Amos
Address:
Denmark (DK)

3

Name:
AMRUTKAR, Dipak, Vasantrao
Address:
Denmark (DK)

4

Name:
JEFSON, Martin, R.
Address:
United States (US)

5

Name:
LARSEN, Janus, Schreiber
Address:
Denmark (DK)

6

Name:
FOSTER, Kelly
Address:
United States (US)

7

Name:
KEANEY, Gregg, F.
Address:
United States (US)

Priority

Priority Number:
201762449270 P
Priority Date:
23/01/2017
Priority Country:
United States (US)

Classification

IPC classification:
C07D 403/04; C07D 417/04; A61P 25/30; A61K 31/506;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2023/05
Publication date:
04/04/2023
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2023/05
Publication date:
04/04/2023
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
202148
Publication date:
01/12/2021
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20230000136A
Date Registered:
21/03/2023
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Changement d’adresse
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
CADENT THERAPEUTICS, INC.
Address:
One Health Plaza East Hanover,, New Jersey, 07936, United States (US)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20230000137A
Date Registered:
21/03/2023
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/01/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
21/03/2023 Request For Change 1
23/03/2023 Outgoing Correspondence 1
21/03/2023 Request For Change 15
23/03/2023 Outgoing Correspondence 1
13/01/2022 Power Of Attorney 1
13/01/2022 Outgoing Correspondence 1